Skip to main content

Table 1 Characteristics of the 94 European studies on patterns of care for breast, colorectal, lung and prostate cancer, published between 2006 and 2016

From: Overuse in cancer care: do European studies provide information useful to support policies?

 

Breast cancer

Colorectal cancer

Lung cancer

Prostate cancer

Miscellaneousa

Total

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

Year of publication

 ≤ 2010

 (%)

11 (29)

(38)

7 (23)

(24)

3 (38)

(10)

4 (44)

(14)

4 (44)

(14)

29 (31)

(100)

 2011–2012

 (%)

11 (29)

(44)

8 (27)

(32)

3 (38)

(12)

1 (11)

(4)

2 (22)

(8)

25 (26.5)

(100)

 2013–2014

 (%)

6 (16)

(24)

13 (43)

(52)

2 (25)

(8)

1 (11)

(4)

3 (33)

(12)

25 (26.5)

(100)

 2015–2016

 (%)

10 (26)

(66.7)

2 (7)

(13.3)

0 (0)

(0)

3 (33)

(20)

0 (0)

(0)

15 (16)

(100)

Study design

 Cross-sectional

 (%)

21 (55.3)

(49)

8 (27)

(19)

4 (50)

(9)

4 (44)

(9)

6 (67)

(14)

43 (46)

(100)

 Cohort

 (%)

17 (44.7)

(33)

22 (73)

(43)

4 (50)

(8)

5 (56)

(10)

3 (33)

(6)

51 (54)

(100)

Data sources

 Cancer registry

 (%)

17 (44.7)

(34.7)

18 (60)

(36.7)

6 (75)

(12.2)

7 (77.8)

(14.2)

1 (11.1)

(2)

49 (52)

(100)

 Cancer registry + administrative databases

 (%)

6 (15.8)

(75)

1 (3.3)

(12.5)

1 (12.5)

(12.5)

0 (0)

(0)

0 (0)

(0)

8 (8)

(100)

 Administrative databases alone

 (%)

8 (21)

(66.7)

1 (3.3)

(8.3)

0 (0)

(0)

1 (11.1)

(8.3)

2 (22.2)

(16.7)

12 (13)

(100)

 Other sources

 (%)

7 (18.4)

(28)

10 (33.3)

(40)

1 (12.5)

(4)

1 (11.1)

(4)

6 (66.7)

(24)

25 (27)

(100)

Type of measures

 Generic

 (%)

17 (44.7)

(3.,4)

16 (53.4)

(33.3)

5 (62.5)

(10.4)

5 (55.5)

(10.4)

5 (55.5)

(10.4)

48 (51)

(100)

 Oriented towards underuse

 (%)

8 (21)

(33.5)

10 (33.3)

(42)

3 (37.5)

(12.5)

1 (11.1)

(4)

2 (22.2)

(8)

24 (26)

(100)

 Oriented towards overuse

 (%)

13 (34.2)

(59.1)

4 (13.3)

(18.2)

0 (0)

(0)

3 (33.3)

(13.6)

2 (22.2)

(9.1)

22 (23)

(100)

 Total

 (%)

38 (100)

(40)

30 (100)

(32.5)

8 (100)

(8.5)

9 (100)

(9.5)

9 (100)

(9.5)

94 (100)

(100)

  1. aStudies including different types of cancers are in this category